Coronavirus | Penn Today

healthcare professional with syringe and vaccine

Ensuring an ethical path to a ‘warp speed’ vaccine

Penn scholars consider the ethical implications of the development and allocation of a COVID-19 vaccine.

How are teens and young adults coping?

Howard Stevenson of the Graduate School of Education and Frances Jensen of the Perelman School of Medicine spoke about how young people view the threat of COVID-19 and the effects of police violence on their mental health.

a group of people walking outside on campus while wearing masks

Using PennOpen Pass for the early detection of COVID-19

The daily symptom tracker is a critical step in ongoing efforts to safely resume academic, research, and clinical activities across campus.

One man’s battle shows why COVID-19 and obesity are a toxic mix

Lewis Kaplan of the Perelman School of Medicine said high levels of body fat can negatively impact one’s chances of surviving COVID-19. “It changes how you evaluate all kinds of considerations, from vascular issues to medications,” he said.

CDC asks latest to plan for potential vaccine distribution starting in late October

Paul Offit of the Perelman School of Medicine said it’s unlikely that a coronavirus vaccine will be ready by the end of the year given that Phase 3 trials have only just begun. Furthermore, he said, insufficient trials could damage not only public health but public trust in vaccines.

Mauro Guillén’s world is about to change

In a new book, the Wharton professor—and “globalization guy”—breaks down the key factors that will combine to radically transform the world over the next decade.

one gloved hand holds syringe and another cleans arm with cotton ball prior to vaccine

How misinformed vaccine beliefs affect policy views

There is broad support in the U.S. for pro-vaccination policies, but as many as 20% of Americans hold negative views about vaccines. The Annenberg Public Policy Center shows that such misinformed vaccine beliefs are the strongest driver of opposition to pro-vaccination public policies.

'Without evidence': Once again, FDA expands use of COVID-19 treatment without research to back it up

Nuala Meyer of the Perelman School of Medicine said she was surprised by the FDA’s approval of remdesivir for patients hospitalized with COVID-19. "We always expect the FDA to base decisions on data and we do get concerned when we see decision-making that we can't find the data to support," she said.

Wharton releases new retail study on customer loyalty

A report from Wharton’s Thomas S. Robertson reveals that consumer disappointment with retailers runs deep.

Uniformed border patrol personnel at a border processing center in a face mask and latex gloves hands an item to a detained person sitting on a bench.

Beth Simmons writes on ‘Pandemic Responses as Border Politics’

Simmons’ article argues that the COVID-19 pandemic ‘reflects growing anxieties about border insecurity in the modern operational system,’ leaving countries to exert more effort at border control.

Filters